| |
| | Clinical Trial: Isoflavones and Acute-Phase Response in Chronic Renal Failure |
 | | This is a randomized, double-blinded dietary intervention in hemodialysis patients to determine the clinical and metabolic effects of soy isoflavones on disease activity, including improvement of blood markers of acute-phase response, and decreased blood levels of markers of metabolic bone disease. |
 | | In the current search for agents that may be able to negate the ongoing acute-phase response of ESRD, the soy isoflavones genistein and daidzein have emerged as potentially useful. |
 | | Acute illness known to cause acute-phase response, including clinically detectable infections, trauma, surgery, burns, and tissue infarction, within the last 6 weeks. |
| www.clinicaltrials.gov /show/NCT00029796 (637 words) |
|